Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: A nationwide follow-up study during 1998-2009

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 277-285

  Chang, Yu Tzu ^a,b   Wu, Jia Ling ^a   Hsu, Chih Cheng ^c   Wang, Jung Der ^a,b   Sung, Junne Ming ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; SCREENING; SEX DIFFERENCE; TAIWAN; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETIC ANGIOPATHIES; KIDNEY FAILURE, CHRONIC; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84890428519     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0781     Document Type: Article

References (40)

1. World Health Organization. Preventing Chronic Diseases: A Vital Investment. Geneva, World Health Organization, 2005
2. Meguid El Nahas A, Bello AK. Chronic kidney disease: The global challenge. Lancet 2005; 365:331-340
3. Levey AS, Coresh J, Balk E, et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139:137-147
4. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-259
5. US Renal Data System. USRDS 2011. Annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States [internet], 2011. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Available from http://www.usrds. org/adr.htm. Accessed 2 May 2012
6. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234
7. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16: 434-444
8. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 2002;13:1918-1927
9. Xue JL, Frazier ET, Herzog CA, Collins AJ. Association of heart disease with diabetes and hypertension in patientswith ESRD. Am J Kidney Dis 2005;45:316-323
10. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-2499
11. Roberts MA, Polkinghorne KR, McDonald SP, Ierino FL. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis 2011; 58:64-72
12. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003;41(Suppl.):11-17
13. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. AmJ Kidney Dis 1998; 32(Suppl. 3):S112-S119
14. Perneger TV, Klag MJ, Whelton PK. Cause of death in patients with end-stage renal disease: Death certificates vs registry reports. Am J Public Health 1993;83:1735-1738
15. National Health Research Institutes. National Health Insurance Research Database [internet]. Available from http://www.nhri.org.tw/nhird/date-01. html#-edn1
16. 2001 National Health Insurance Annual Statistical Report. Taipei, Taiwan, Bureau of National Health Insurance, 2002
17. Lai MN, Wang SM, Chen PC, Chen YY, Wang JD. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 2010;102:179-186
18. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009;137:1641-1648.
19. Tsan YT, Lee CH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012;30:623-630
20. Wang JD. Basic Principles and Practical Applications in Epidemiological Research. Singapore, World Scientific, 2002, p. 135-137
21. Davis W. Cancer Registration and Its Techniques. Lyon, International Agency for Research on Cancer, 1978, p. 162-163
22. Yang WC, Hwang SJ; Taiwan Society of Nephrology. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: The impact of national health insurance. Nephrol Dial Transplant 2008;23:3977-3982
23. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000;35(Suppl. 1):S117-S131
24. Tripepi G, Mattace Raso F, Sijbrands E, et al. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol 2011;6:1714-1721
25. Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 2007;30:1834-1839
26. Hayden JM, Reaven PD. Cardiovascular disease in diabetes mellitus type 2: A potential role for novel cardiovascular risk factors. Curr Opin Lipidol 2000;11:519-528
27. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439
28. Barreto FC, Barreto DV, Liabeuf S, et al.; European Uremic Toxin Work Group (EUTox). Serumindoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:1551-1558
29. Ritz E, Dikow R, Adamzcak M, Zeier M. Congestive heart failure due to systolic dysfunction: The Cinderella of cardiovascular management in dialysis patients. Semin Dial 2002;15:135-140
30. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362
31. Prinsen BH, Rabelink TJ, Romijn JA, et al. A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis. Kidney Int 2004;65:1064-1075
32. Anand SS, Islam S, Rosengren A, et al.; INTERHEART Investigators. Risk factors for myocardial infarction in women and men: Insights from the INTERHEART study. Eur Heart J 2008;29:932-940
33. Kappert K, Bohm M, Schmieder R, et al.; ONTARGET/TRANSCEND Investigators. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation 2012; 126:934-941
34. Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: Heart disease and stroke statisticsd2012 update: A report from the American Heart Association. Circulation 2012;125:188-197
35. Lam CS, Little WC. Sex and cardiovascular risk: Are women advantaged or men disadvantaged Circulation 2012;126:913-915
36. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al.; SWAN Investigators. Sexhormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242-1249
37. Karakitsos D, Patrianakos AP, De Groot E, et al. Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis. Am J Nephrol 2006;26:536-543
38. Khan NA, Wang H, Anand S, et al. Ethnicity and sex affect diabetes incidence and outcomes. Diabetes Care 2011;34:96-101
39. ODonnell MJ, Xavier D, Liu L, et al.; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 2010; 376:112-123
40. Yusuf S, Hawken S, Ounpuu S, et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Casecontrol study. Lancet 2004;364:937-952